Molteno3 Implantation as Primary Glaucoma Surgery
Purpose. To determine the outcome of Molteno3 implantation as primary glaucoma surgery and to analyze the factors influencing the surgical outcome. Methods. This is a retrospective clinical study of 106 consecutive eyes (97 patients) with no previous glaucoma surgery. Surgical failure was defined as...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2014/167564 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849305307024457728 |
|---|---|
| author | Juha O. Välimäki Ari-Pekka A. Ylilehto |
| author_facet | Juha O. Välimäki Ari-Pekka A. Ylilehto |
| author_sort | Juha O. Välimäki |
| collection | DOAJ |
| description | Purpose. To determine the outcome of Molteno3 implantation as primary glaucoma surgery and to analyze the factors influencing the surgical outcome. Methods. This is a retrospective clinical study of 106 consecutive eyes (97 patients) with no previous glaucoma surgery. Surgical failure was defined as an IOP > 21 mmHg or less than a 20% reduction below baseline, or IOP ≤ 5 mmHg, on two consecutive visits after 3 months follow-up, or reoperation for glaucoma or loss of light perception. Results. At the end of the follow-up (mean, 35 months; range, 12–71 months), the mean postoperative IOP (14.2 ± 4.4 mmHg) was statistically significantly lower than the preoperative IOP (35.2 ± 9.7 mmHg) (P<0.001). Life-table success rates were 97%, 94%, and 91% after follow-up of 12, 24, and 36 months, respectively. Success rate for an IOP ≤ 18 mmHg was 77% at the last visit. Success was not influenced by previous cataract surgery, sex, age, laser trabeculoplasty (LTP), preoperative IOP, or number of antiglaucoma medications. Forty-seven eyes had 66 postoperative complications. Conclusions. The primary Molteno3 implant provided significant IOP lowering with minimal and manageable complications in uncontrolled glaucoma. Neither previous cataract surgery nor LTP had any detrimental effect on surgical success. |
| format | Article |
| id | doaj-art-08f3ce4f988b4bc5a8fc41edd805215a |
| institution | Kabale University |
| issn | 2090-004X 2090-0058 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj-art-08f3ce4f988b4bc5a8fc41edd805215a2025-08-20T03:55:29ZengWileyJournal of Ophthalmology2090-004X2090-00582014-01-01201410.1155/2014/167564167564Molteno3 Implantation as Primary Glaucoma SurgeryJuha O. Välimäki0Ari-Pekka A. Ylilehto1Department of Ophthalmology, Päijät-Häme Central Hospital, Keskussairaalankatu 7, FIN-15850 Lahti, FinlandDepartment of Ophthalmology, Päijät-Häme Central Hospital, Keskussairaalankatu 7, FIN-15850 Lahti, FinlandPurpose. To determine the outcome of Molteno3 implantation as primary glaucoma surgery and to analyze the factors influencing the surgical outcome. Methods. This is a retrospective clinical study of 106 consecutive eyes (97 patients) with no previous glaucoma surgery. Surgical failure was defined as an IOP > 21 mmHg or less than a 20% reduction below baseline, or IOP ≤ 5 mmHg, on two consecutive visits after 3 months follow-up, or reoperation for glaucoma or loss of light perception. Results. At the end of the follow-up (mean, 35 months; range, 12–71 months), the mean postoperative IOP (14.2 ± 4.4 mmHg) was statistically significantly lower than the preoperative IOP (35.2 ± 9.7 mmHg) (P<0.001). Life-table success rates were 97%, 94%, and 91% after follow-up of 12, 24, and 36 months, respectively. Success rate for an IOP ≤ 18 mmHg was 77% at the last visit. Success was not influenced by previous cataract surgery, sex, age, laser trabeculoplasty (LTP), preoperative IOP, or number of antiglaucoma medications. Forty-seven eyes had 66 postoperative complications. Conclusions. The primary Molteno3 implant provided significant IOP lowering with minimal and manageable complications in uncontrolled glaucoma. Neither previous cataract surgery nor LTP had any detrimental effect on surgical success.http://dx.doi.org/10.1155/2014/167564 |
| spellingShingle | Juha O. Välimäki Ari-Pekka A. Ylilehto Molteno3 Implantation as Primary Glaucoma Surgery Journal of Ophthalmology |
| title | Molteno3 Implantation as Primary Glaucoma Surgery |
| title_full | Molteno3 Implantation as Primary Glaucoma Surgery |
| title_fullStr | Molteno3 Implantation as Primary Glaucoma Surgery |
| title_full_unstemmed | Molteno3 Implantation as Primary Glaucoma Surgery |
| title_short | Molteno3 Implantation as Primary Glaucoma Surgery |
| title_sort | molteno3 implantation as primary glaucoma surgery |
| url | http://dx.doi.org/10.1155/2014/167564 |
| work_keys_str_mv | AT juhaovalimaki molteno3implantationasprimaryglaucomasurgery AT aripekkaaylilehto molteno3implantationasprimaryglaucomasurgery |